Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: BREAST NEOPLASMS - PATHOLOGY , . Treffer: 176

2022

Singer, CF; Jahn, SW; Rudas, M; Bago-Horvath, Z; Fitzal, F; Abete, L; Moinfar, F; Gnant, M; Filipits, M, , Austrian, Breast, and, Colorectal, Cancer, Study, Group, (ABCSG) Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry.
Breast. 2022; 64:127-133 Doi: 10.1016/j.breast.2022.05.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wienerroither, V; Hammer, R; Kornprat, P; Schrem, H; Wagner, D; Mischinger, HJ; El-Shabrawi, A Use of LigaSure vessel sealing system versus conventional axillary dissection in breast cancer patients: a retrospective comparative study.
BMC Surg. 2022; 22(1):436 Doi: 10.1186/s12893-022-01888-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Dubsky, PC; Singer, CF; Egle, D; Wette, V; Petru, E; Balic, M; Pichler, A; Greil, R; Petzer, AL; Bago-Horvath, Z; Fesl, C; Meek, SM; Kronenwett, R; Rudas, M; Gnant, M; Filipits, M; Austrian Breast and Colorectal Cancer Study Group The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Eur J Cancer. 2020; 134:99-106 Doi: 10.1016/j.ejca.2020.04.020 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hurvitz, SA; Martin, M; Press, MF; Chan, D; Fernandez-Abad, M; Petru, E; Rostorfer, R; Guarneri, V; Huang, CS; Barriga, S; Wijayawardana, S; Brahmachary, M; Ebert, PJ; Hossain, A; Liu, J; Abel, A; Aggarwal, A; Jansen, VM; Slamon, DJ Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR⁺/HER2^- Breast Cancer.
CLIN CANCER RES. 2020; 26(3): 566-580. Doi: 10.1158/1078-0432.CCR-19-1425 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lord, SR; Collins, JM; Cheng, WC; Haider, S; Wigfield, S; Gaude, E; Fielding, BA; Pinnick, KE; Harjes, U; Segaran, A; Jha, P; Hoefler, G; Pollak, MN; Thompson, AM; Roy, PG; English, R; Adams, RF; Frezza, C; Buffa, FM; Karpe, F; Harris, AL Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin.
Br J Cancer. 2020; 122(2):258-265 Doi: 10.1038/s41416-019-0665-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stöger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Maria Tea, MK; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M; Austrian Breast & Colorectal Cancer Study Group Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Eur J Cancer. 2020; 132:43-52 Doi: 10.1016/j.ejca.2020.03.018
Web of Science PubMed FullText FullText_MUG

 

2019

Strell, C; Paulsson, J; Jin, SB; Tobin, NP; Mezheyeuski, A; Roswall, P; Mutgan, C; Mitsios, N; Johansson, H; Wickberg, SM; Svedlund, J; Nilsson, M; Hall, P; Mulder, J; Radisky, DC; Pietras, K; Bergh, J; Lendahl, U; Wärnberg, F; Östman, A Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
J Natl Cancer Inst. 2019; 111(9):983-995 Doi: 10.1093/jnci/djy234 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stumptner, C; Pabst, D; Loibner, M; Viertler, C; Zatloukal, K The impact of crosslinking and non-crosslinking fixatives on antigen retrieval and immunohistochemistry.
N Biotechnol. 2019; 52:69-83 Doi: 10.1016/j.nbt.2019.05.003
Web of Science PubMed FullText FullText_MUG

 

2018

Cserni, G; Zombori, T; Andreu, X; Bianchi, S; Regitnig, P; Amendoeira, I; Balmativola, D; Kovács, A; Cordoba, A; Reiner, A; Kulka, J; Kaya, H; Liepniece-Karele, I; Quinn, C; Kővári, B Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?
Pathol Oncol Res. 2018; 24(1):167-170 Doi: 10.1007/s12253-017-0229-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Partl, R; Regitnig, P; Tauber, G; Pötscher, M; Bjelic-Radisic, V; Kapp, KS Radiation-induced morphea-a rare but severe late effect of adjuvant breast irradiation : Case report and review of the literature.
Strahlenther Onkol. 2018; 194(11): 1060-1065. Doi: 10.1007/s00066-018-1336-9 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Alduk, AM; Brcic, I; Podolski, P; Prutki, M Correlation of MRI features and pathohistological prognostic factors in invasive ductal breast carcinoma.
Acta Clin Belg. 2017; 72(5):306-312 Doi: 10.1080/17843286.2016.1266432
Web of Science PubMed FullText FullText_MUG

 

Bayraktar, R; Pichler, M; Kanlikilicer, P; Ivan, C; Bayraktar, E; Kahraman, N; Aslan, B; Oguztuzun, S; Ulasli, M; Arslan, A; Calin, G; Lopez-Berestein, G; Ozpolat, B MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
Oncotarget. 2017; 8(7): 11641-11658. Doi: 10.18632/oncotarget.14264 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Cserni, G; Floris, G; Koufopoulos, N; Kovács, A; Nonni, A; Regitnig, P; Stahls, A; Varga, Z Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases.
Virchows Arch. 2017; 471(1):3-12 Doi: 10.1007/s00428-017-2147-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Foschini, MP; Miglio, R; Quinn, C; Belgio, B; Regitnig, P; Bianchi, S; Nannini, R; Buerger, H; Kaya, H; Illyés, I; Kulka, J; Wells, CA; De Gaetano, J; Lipeniece-Karele, I; Cserni, G Prognostic impact of macrometastasis linear size in sentinel node biopsy for breast carcinoma.
Eur J Surg Oncol. 2017; 43(8):1421-1427 Doi: 10.1016/j.ejso.2017.05.007 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Nass, N; Walter, S; Jechorek, D; Weissenborn, C; Ignatov, A; Haybaeck, J; Sel, S; Kalinski, T High neuronatin (NNAT) expression is associated with poor outcome in breast cancer.
Virchows Arch. 2017; 471(1): 23-30. Doi: 10.1007/s00428-017-2154-7
Web of Science PubMed FullText FullText_MUG

 

Schramm, A; Schochter, F; Friedl, TWP; de Gregorio, N; Andergassen, U; Alunni-Fabbroni, M; Trapp, E; Jaeger, B; Heinrich, G; Camara, O; Decker, T; Ober, A; Mahner, S; Fehm, TN; Pantel, K; Fasching, PA; Schneeweiss, A; Janni, W; Rack, BK; SUCCESS Study Group Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Clin Breast Cancer. 2017; 17(4):279-285 Doi: 10.1016/j.clbc.2016.11.008
Web of Science PubMed FullText FullText_MUG

 

Singer, CF; Tan, YY; Fitzal, F; Steger, GG; Egle, D; Reiner, A; Rudas, M; Moinfar, F; Gruber, C; Petru, E; Bartsch, R; Tendl, KA; Fuchs, D; Seifert, M; Exner, R; Balic, M; Bago-Horvath, Z; Filipits, M; Gnant, M; Austrian Breast and Colorectal Cancer Study Group Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer.
Clin Cancer Res. 2017; 23(14):3676-3683 Doi: 10.1158/1078-0432.CCR-16-2373 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tiran, V; Stanzer, S; Heitzer, E; Meilinger, M; Rossmann, C; Lax, S; Tsybrovskyy, O; Dandachi, N; Balic, M Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
PLoS One. 2017; 12(4):e0175223-e0175223 Doi: 10.1371/journal.pone.0175223 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Trapp, EK; Majunke, L; Zill, B; Sommer, H; Andergassen, U; Koch, J; Harbeck, N; Mahner, S; Friedl, TWP; Janni, W; Rack, B; Alunni-Fabbroni, M LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Mol Oncol. 2017; 11(11):1508-1526 Doi: 10.1002/1878-0261.12111 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weber, WP; Soysal, SD; El-Tamer, M; Sacchini, V; Knauer, M; Tausch, C; Hauser, N; Günthert, A; Harder, Y; Kappos, EA; Schwab, F; Fitzal, F; Dubsky, P; Bjelic-Radisic, V; Reitsamer, R; Koller, R; Heil, J; Hahn, M; Blohmer, JU; Hoffmann, J; Solbach, C; Heitmann, C; Gerber, B; Haug, M; Kurzeder, C First international consensus conference on standardization of oncoplastic breast conserving surgery.
Breast Cancer Res Treat. 2017; 165(1):139-149 Doi: 10.1007/s10549-017-4314-5
Web of Science PubMed FullText FullText_MUG

 

2016

Cerk, S; Schwarzenbacher, D; Adiprasito, JB; Stotz, M; Hutterer, GC; Gerger, A; Ling, H; Calin, GA; Pichler, M Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Int J Mol Sci. 2016; 17(9): Doi: 10.3390/ijms17091485 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Chan, AA; Bashir, M; Rivas, MN; Duvall, K; Sieling, PA; Pieber, TR; Vaishampayan, PA; Love, SM; Lee, DJ Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors.
Sci Rep. 2016; 6(36):28061-28061 Doi: 10.1038/srep28061 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hepp, P; Andergassen, U; Jäger, B; Trapp, E; Alunni-Fabbroni, M; Friedl, TW; Hecker, N; Lorenz, R; Fasching, P; Schneeweiss, A; Fehm, T; Janni, W; Rack, B Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
Anticancer Res. 2016; 36(9):4771-4776 Doi: 10.21873/anticanres.11034 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jueckstock, J; Rack, B; Friedl, TW; Scholz, C; Steidl, J; Trapp, E; Tesch, H; Forstbauer, H; Lorenz, R; Rezai, M; Häberle, L; Alunni-Fabbroni, M; Schneeweiss, A; Beckmann, MW; Lichtenegger, W; Fasching, PA; Pantel, K; Janni, W; SUCCESS Study Group Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
BMC Cancer. 2016; 16(10):401-401 Doi: 10.1186/s12885-016-2454-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

König, A; Vilsmaier, T; Rack, B; Friese, K; Janni, W; Jeschke, U; Andergassen, U; Trapp, E; Jückstock, J; Jäger, B; Alunni-Fabbroni, M; Friedl, T; Weissenbacher, T; SUCCESS STUDY GROUP Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.
Anticancer Res. 2016; 36(6):3123-3130
Web of Science PubMed

 

Rack, B; Jückstock, J; Trapp, E; Weissenbacher, T; Alunni-Fabbroni, M; Schramm, A; Widschwendter, P; Lato, K; Zwingers, T; Lorenz, R; Tesch, H; Schneeweiss, A; Fasching, P; Mahner, S; Beckmann, MW; Lichtenegger, W; Janni, W; SUCCESS Study Group CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Tumour Biol. 2016; 37(10):13769-13775 Doi: 10.1007/s13277-016-5171-2
Web of Science PubMed FullText FullText_MUG

 

Rack, B; Zombirt, E; Trapp, E; Jückstock, J; Andergassen, U; Neugebauer, J; Kost, B; Weissenbacher, T; Jeschke, U; Schindlbeck, C; Janni, W; Alunni-Fabbroni, M Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
Oncology. 2016; 90(4):232-238 Doi: 10.1159/000442986 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rasoulzadeh, Z; Ghods, R; Kazemi, T; Mirzadegan, E; Ghaffari-Tabrizi-Wizsy, N; Rezania, S; Kazemnejad, S; Arefi, S; Ghasemi, J; Vafaei, S; Mahmoudi, AR; Zarnani, AH Placental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells.
PLoS One. 2016; 11(4):e0153684-e0153684 Doi: 10.1371/journal.pone.0153684 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schramm, A; Friedl, TW; Schochter, F; Scholz, C; de Gregorio, N; Huober, J; Rack, B; Trapp, E; Alunni-Fabbroni, M; Müller, V; Schneeweiss, A; Pantel, K; Meier-Stiegen, F; Hartkopf, A; Taran, FA; Wallwiener, D; Janni, W; Fehm, T Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
Arch Gynecol Obstet. 2016; 293(2):271-281 Doi: 10.1007/s00404-015-3879-7
Web of Science PubMed FullText FullText_MUG

 

Sigl, V; Owusu-Boaitey, K; Joshi, PA; Kavirayani, A; Wirnsberger, G; Novatchkova, M; Kozieradzki, I; Schramek, D; Edokobi, N; Hersl, J; Sampson, A; Odai-Afotey, A; Lazaro, C; Gonzalez-Suarez, E; Pujana, MA; Cimba, F; Heyn, H; Vidal, E; Cruickshank, J; Berman, H; Sarao, R; Ticevic, M; Uribesalgo, I; Tortola, L; Rao, S; Tan, Y; Pfeiler, G; Lee, EY; Bago-Horvath, Z; Kenner, L; Popper, H; Singer, C; Khokha, R; Jones, LP; Penninger, JM RANKL/RANK control Brca1 mutation- .
Cell Res. 2016; 26(7):761-774 Doi: 10.1038/cr.2016.69 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Dorner, N; Kühs, U; Aufderklamm, S; Rausch, S; Bier, S; Mischinger, J; Schellbach, D; Hauch, S; Feniuk, N; Bedke, J; Gakis, G; Stenzl, A; Schwentner, C Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
J Cancer Res Clin Oncol. 2016; 142(5):1013-1020 Doi: 10.1007/s00432-016-2129-0
Web of Science PubMed FullText FullText_MUG

 

Tramm, T; Kim, JY; Leibl, S; Moinfar, F; Tavassoli, FA Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.
Virchows Arch. 2016; 469(3):285-295 Doi: 10.1007/s00428-016-1966-1
Web of Science PubMed FullText FullText_MUG

 

Trivanović, D; Jauković, A; Krstić, J; Nikolić, S; Okić Djordjević, I; Kukolj, T; Obradović, H; Mojsilović, S; Ilić, V; Santibanez, JF; Bugarski, D Inflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF-7 breast cancer cells via transforming growth factor-β1.
IUBMB Life. 2016; 68(3): 190-200. Doi: 10.1002/iub.1473 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zhang, F; Wang, X; Xu, X; Li, M; Zhou, J; Wang, W Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Eur J Pharm Sci. 2016; 92(36):11-21 Doi: 10.1016/j.ejps.2016.06.017
Web of Science PubMed FullText FullText_MUG

 

2015

Bossuyt, V; Provenzano, E; Symmans, WF; Boughey, JC; Coles, C; Curigliano, G; Dixon, JM; Esserman, LJ; Fastner, G; Kuehn, T; Peintinger, F; von Minckwitz, G; White, J; Yang, W; Badve, S; Denkert, C; MacGrogan, G; Penault-Llorca, F; Viale, G; Cameron, D; Breast International Group-North American Breast Cancer Group (BIG-NABCG) collaboration Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.
ANN ONCOL. 2015; 26(7): 1280-1291. Doi: 10.1093/annonc/mdv161 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fastner, G; Reitsamer, R; Ziegler, I; Zehentmayr, F; Fussl, C; Kopp, P; Peintinger, F; Greil, R; Fischer, T; Deutschmann, H; Sedlmayer, F IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Int J Cancer. 2015; 136(5): 1193-1201. Doi: 10.1002/ijc.29064 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fitzal, F; Filipits, M; Rudas, M; Greil, R; Dietze, O; Samonigg, H; Lax, S; Herz, W; Dubsky, P; Bartsch, R; Kronenwett, R; Gnant, M The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
Br J Cancer. 2015; 112(8):1405-1410 Doi: 10.1038/bjc.2015.98 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Geltmeier, A; Rinner, B; Bade, D; Meditz, K; Witt, R; Bicker, U; Bludszuweit-Philipp, C; Maier, P Characterization of Dynamic Behaviour of MCF7 and MCF10A Cells in Ultrasonic Field Using Modal and Harmonic Analyses.
PLoS One. 2015; 10(8):e0134999-e0134999 Doi: 10.1371/journal.pone.0134999 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Ann Oncol. 2015; 26(8):1685-1691 Doi: 10.1093/annonc/mdv215 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gorensek, K; Arzberger, E; Hofmann-Wellenhof, R [Pigmented macule on the neck, red nodules on the trunk. Diagnosis: neck left: Melanoma. Pectoral right: Breast cancer].
Hautarzt. 2015; 66(12):964-966 Doi: 10.1007/s00105-015-3683-0 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Li, C; Rezania, S; Kammerer, S; Sokolowski, A; Devaney, T; Gorischek, A; Jahn, S; Hackl, H; Groschner, K; Windpassinger, C; Malle, E; Bauernhofer, T; Schreibmayer, W Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line.
Sci Rep. 2015; 5(2):8364-8364 Doi: 10.1038/srep08364 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Peintinger, F; Sinn, B; Hatzis, C; Albarracin, C; Downs-Kelly, E; Morkowski, J; Gould, R; Symmans, WF Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.
MODERN PATHOL. 2015; 28(7): 913-920. Doi: 10.1038/modpathol.2015.53 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pircher, M; Mlineritsch, B; Fridrik, MA; Dittrich, C; Lang, A; Petru, E; Weltermann, A; Thaler, J; Hufnagl, C; Gampenrieder, SP; Rinnerthaler, G; Ressler, S; Ulmer, H; Greil, R Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.
Anticancer Res. 2015; 35(1):517-521
Web of Science PubMed

 

Provenzano, E; Bossuyt, V; Viale, G; Cameron, D; Badve, S; Denkert, C; MacGrogan, G; Penault-Llorca, F; Boughey, J; Curigliano, G; Dixon, JM; Esserman, L; Fastner, G; Kuehn, T; Peintinger, F; von Minckwitz, G; White, J; Yang, W; Symmans, WF; Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.
MODERN PATHOL. 2015; 28(9): 1185-1201. Doi: 10.1038/modpathol.2015.74 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schwarzenbacher, D; Stiegelbauer, V; Deutsch, A; Ress, AL; Aigelsreiter, A; Schauer, S; Wagner, K; Langsenlehner, T; Resel, M; Gerger, A; Ling, H; Ivan, C; Calin, GA; Hoefler, G; Rinner, B; Pichler, M Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Oncotarget. 2015; 6(13):11191-11202 Doi: 10.18632/oncotarget.3586 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Suppan, C; Bjelic-Radisic, V; La Garde, M; Groselj-Strele, A; Eberhard, K; Samonigg, H; Loibner, H; Dandachi, N; Balic, M Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.
BMC Cancer. 2015; 15:1027-1027 Doi: 10.1186/s12885-015-2005-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Widschwendter, P; Friedl, TW; Schwentner, L; DeGregorio, N; Jaeger, B; Schramm, A; Bekes, I; Deniz, M; Lato, K; Weissenbacher, T; Kost, B; Andergassen, U; Jueckstock, J; Neugebauer, J; Trapp, E; Fasching, PA; Beckmann, MW; Schneeweiss, A; Schrader, I; Rack, B; Janni, W; Scholz, C The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.
Breast Cancer Res. 2015; 17(4):129-129 Doi: 10.1186/s13058-015-0639-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Cserni, G; Vörös, A; Liepniece-Karele, I; Bianchi, S; Vezzosi, V; Grabau, D; Sapino, A; Castellano, I; Regitnig, P; Foschini, MP; Zolota, V; Varga, Z; Figueiredo, P; Decker, T; Focke, C; Kulka, J; Kaya, H; Reiner-Concin, A; Amendoeira, I; Callagy, G; Caffrey, E; Wesseling, J; Wells, C Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values.
Breast. 2014; 23(3):259-263 Doi: 10.1016/j.breast.2014.02.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Filipits, M; Greil, R; Stoeger, H; Rudas, M; Bago-Horvath, Z; Mlineritsch, B; Kwasny, W; Knauer, M; Singer, C; Jakesz, R; Dubsky, P; Fitzal, F; Bartsch, R; Steger, G; Balic, M; Ressler, S; Cowens, JW; Storhoff, J; Ferree, S; Schaper, C; Liu, S; Fesl, C; Nielsen, TO; Austrian Breast and Colorectal Cancer Study Group Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Ann Oncol. 2014; 25(2):339-345 Doi: 10.1093/annonc/mdt494 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Luschin, G; Habersack, M Oral information about side effects of endocrine therapy for early breast cancer patients at initial consultation and first follow-up visit: an online survey.
Health Commun. 2014; 29(4):421-426 Doi: 10.1080/10410236.2012.743096
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum